Tonix Pharmaceuticals Holding Corp
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +347.2% | +28.0% | -66.0% | -22.9% | -51.9% | +3.8% | +85.2% | +2,406.0% | +242.5% | -20.3% | -43.7% | |
| – | +42.1% | -25.6% | -45.2% | -9.1% | -10.4% | +97.4% | +174.7% | +38.2% | -15.0% | -48.5% | +25.9% | |
| – | +42.1% | -22.6% | -47.3% | -9.1% | -10.4% | +190.7% | +157.3% | +0.1% | – | – | – | |
| – | -6.5% | -312.9% | – | +223.7% | +3.4% | -623.5% | – | -100.0% | – | – | +48.0% | |
| – | -25.4% | -72.3% | -92.4% | +20.0% | +183.3% | +50,276.5% | +312.3% | +36.4% | -83.6% | -98.5% | +2,707.5% | |
| – | +6,066.1% | – | -56.8% | -100.1% | +183.3% | +50,276.5% | +312.3% | +36.4% | -39.6% | -99.6% | +3,673.3% | |
| – | – | – | – | – | -24.2% | -81.8% | – | – | – | – | – | |
| – | -10.8% | -99.6% | -55.7% | +31,709.5% | -45.1% | -89.5% | +120.6% | -1,675.0% | -70.4% | -100.0% | – | |
| – | – | – | – | – | – | – | – | – | – | -126.3% | +310.6% | |
| – | -10.4% | -57.0% | -9.7% | +27.1% | -45.1% | +852.9% | +72.6% | -58.7% | -58.4% | +269.3% | +59.1% | |
| – | -163.4% | – | – | -106.9% | – | – | +54.0% | -157.5% | – | – | +49.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.